BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18350269)

  • 21. Intensive insulin therapy for critically ill patients.
    Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
    Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive insulin therapy in high-risk cardiac surgery patients: evidence from the Leuven randomized study.
    Vanhorebeek I; Ingels C; Van den Berghe G
    Semin Thorac Cardiovasc Surg; 2006; 18(4):309-16. PubMed ID: 17395027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive insulin therapy and mortality in critically ill patients.
    Treggiari MM; Karir V; Yanez ND; Weiss NS; Daniel S; Deem SA
    Crit Care; 2008; 12(1):R29. PubMed ID: 18312617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tight glucose control in critically ill children--a systematic review and meta-analysis.
    Srinivasan V; Agus MS
    Pediatr Diabetes; 2014 Mar; 15(2):75-83. PubMed ID: 24783254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should guidelines for glycemic control of the critically ill be individualized?: Weighing the evidence from randomized and observational investigations.
    Krinsley JS
    Hosp Pract (1995); 2014 Apr; 42(2):14-22. PubMed ID: 24769780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the "SPECS" of the safe pediatric euglycemia after cardiac surgery study: thinking outside the box for safer control of blood glucose in the ICU.
    Srinivasan V
    Pediatr Crit Care Med; 2013 Feb; 14(2):226-7. PubMed ID: 23388571
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of intravenous insulin therapy in critically ill patients.
    Van den Berghe GH
    Endocr Pract; 2004; 10 Suppl 2():17-20. PubMed ID: 15251636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive insulin therapy and the bath insulin protocol.
    Saxena M; O'Leary M; Jacques T
    Anaesth Intensive Care; 2005 Feb; 33(1):141; author reply 141-2. PubMed ID: 15957706
    [No Abstract]   [Full Text] [Related]  

  • 29. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?
    Vanhorebeek I; Langouche L; Van den Berghe G
    Curr Opin Crit Care; 2005 Aug; 11(4):304-11. PubMed ID: 16015107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose metabolism and insulin therapy.
    Langouche L; Van den Berghe G
    Crit Care Clin; 2006 Jan; 22(1):119-29, vii. PubMed ID: 16399023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of hyperglycemia in adult, critically ill patients (Update 2019)].
    Clodi M; Resl M; Abrahamian H; Föger B; Weitgasser R
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):218-220. PubMed ID: 30980173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients.
    Pinelli NR; Jones MC; Monday LM; Smith Z; Rhoney DH
    Ann Pharmacother; 2012 Jan; 46(1):124-9. PubMed ID: 22202493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-hospital hyperglycemia: quo vadis?
    Sechterberger MK; Siegelaar SE; DeVries JH
    Diabetes Technol Ther; 2011 Nov; 13(11):1081-4. PubMed ID: 21932998
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intensive insulin therapy in critically ill patients--contra].
    Marx G; Brunkhorst FM; Reinhart K
    Dtsch Med Wochenschr; 2006 Nov; 131(44):2481. PubMed ID: 17066360
    [No Abstract]   [Full Text] [Related]  

  • 35. Tighten up glycemic control. Aggressive insulin therapy in critical care settings is the latest method of reducing mortality rates.
    Spuhler VJ; Veale K
    Nursing; 2007; 37 Suppl Critical():10-3. PubMed ID: 17440331
    [No Abstract]   [Full Text] [Related]  

  • 36. Implementing glucose control protocols in critically ill patients.
    Susla GM
    AACN Adv Crit Care; 2007; 18(1):5-9. PubMed ID: 17284942
    [No Abstract]   [Full Text] [Related]  

  • 37. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study.
    Vlasselaers D; Milants I; Desmet L; Wouters PJ; Vanhorebeek I; van den Heuvel I; Mesotten D; Casaer MP; Meyfroidt G; Ingels C; Muller J; Van Cromphaut S; Schetz M; Van den Berghe G
    Lancet; 2009 Feb; 373(9663):547-56. PubMed ID: 19176240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperglycemia management using insulin in the acute care setting: therapies and strategies for care in the non-critically ill patient.
    Kirk JK; Oldham EC
    Ann Pharmacother; 2010; 44(7-8):1222-30. PubMed ID: 20571106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic control in the critically ill patient an update: hyperglycemia, glucose variability hypoglycemia and relative hypoglycemia].
    Pérez-Calatayud ÁA; Guillén-Vidaña A; Fraire-Félix IS; Anica-Malagón ED; Briones Garduño JC; Carrillo-Esper R
    Cir Cir; 2017; 85(1):93-100. PubMed ID: 27998542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized controlled trials.
    Zhao Y; Wu Y; Xiang B
    Pediatr Res; 2018 May; 83(5):930-935. PubMed ID: 29244792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.